User profiles for Mirella Filocamo
Mirella FilocamoG. Gaslini Institute, Genova, Italy Verified email at gaslini.org Cited by 7222 |
Germline mutations in HRAS proto-oncogene cause Costello syndrome
…, K Kurosawa, H Ohashi, Y Tanaka, M Filocamo… - Nature …, 2005 - nature.com
Costello syndrome is a multiple congenital anomaly and mental retardation syndrome
characterized by coarse face, loose skin, cardiomyopathy and predisposition to tumors. We …
characterized by coarse face, loose skin, cardiomyopathy and predisposition to tumors. We …
[HTML][HTML] Lysosomal storage disorders: molecular basis and laboratory testing
M Filocamo, A Morrone - Human genomics, 2011 - Springer
Lysosomal storage disorders (LSDs) are a large group of more than 50 different inherited
metabolic diseases which, in the great majority of cases, result from the defective function of …
metabolic diseases which, in the great majority of cases, result from the defective function of …
[HTML][HTML] GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings
…, A d'Amico, A d'Azzo, E Bertini, M Filocamo… - … et Biophysica Acta (BBA …, 2011 - Elsevier
GM1 gangliosidosis and Morquio B syndrome, both arising from beta-galactosidase (GLB1)
deficiency, are very rare lysosomal storage diseases with an incidence of about 1:100,000–1…
deficiency, are very rare lysosomal storage diseases with an incidence of about 1:100,000–1…
Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
I Bendikov-Bar, G Maor, M Filocamo… - Blood Cells, Molecules …, 2013 - Elsevier
Gaucher disease (GD) is characterized by accumulation of glucosylceramide in lysosomes
due to mutations in the GBA1 gene encoding the lysosomal hydrolase β-glucocerebrosidase (…
due to mutations in the GBA1 gene encoding the lysosomal hydrolase β-glucocerebrosidase (…
Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy
…, G Amico, F Fumagalli, I Spiga, M Filocamo… - Human …, 2016 - Wiley Online Library
Metachromatic leukodystrophy is a neurodegenerative disorder characterized by progressive
demyelination. The disease is caused by variants in the ARSA gene, which codes for the …
demyelination. The disease is caused by variants in the ARSA gene, which codes for the …
[HTML][HTML] Unfolded protein response in Gaucher disease: from human to Drosophila
Background In Gaucher disease (GD), resulting from mutations in the GBA gene, mutant β-glucocerebrosidase
(GCase) molecules are recognized as misfolded in the endoplasmic …
(GCase) molecules are recognized as misfolded in the endoplasmic …
Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease
The characterization of the underlying GALC gene lesions was performed in 30 unrelated
patients affected by Krabbe disease, an autosomal recessive leukodystrophy caused by the …
patients affected by Krabbe disease, an autosomal recessive leukodystrophy caused by the …
[HTML][HTML] Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2 diabetes
…, I Le Pera, B Arcidiacono, M Filocamo… - Nature …, 2010 - nature.com
Processed pseudogenes are non-functional copies of normal genes that arise by a process
of mRNA retrotransposition. The human genome contains thousands of pseudogenes; …
of mRNA retrotransposition. The human genome contains thousands of pseudogenes; …
Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant
I Bendikov-Bar, I Ron, M Filocamo… - Blood Cells, Molecules …, 2011 - Elsevier
A large number of mutations in the glucocerebrosidase gene (GBA gene), encoding the
lysosomal acid hydrolase glucocerebrosidase (GCase), lead to Gaucher disease (GD). The …
lysosomal acid hydrolase glucocerebrosidase (GCase), lead to Gaucher disease (GD). The …
[HTML][HTML] Pharmacological enhancement of mutated α-glucosidase activity in fibroblasts from patients with Pompe disease
…, C Porto, F Donaudy, B Rossi, M Rossi, M Filocamo… - Molecular Therapy, 2007 - cell.com
We investigated the use of pharmacological chaperones for the therapy of Pompe disease,
a metabolic myopathy due to mutations of the gene encoding the lysosomal hydrolase α-…
a metabolic myopathy due to mutations of the gene encoding the lysosomal hydrolase α-…